Transaction · 0001225208-26-008338

Lippis Daniel J.

Lippis Daniel J., CVP, TAVR, reported a transaction classified as exercise at Edwards Lifesciences Corp involving 619.000000 shares for an estimated $44988.92. Reported holdings after the transaction were 40652.910300 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MCVP, TAVR
EWEdwards Lifesciences Corp
Filing timeOct 08
Trade dateOct 08, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableCalculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$84.24
Pre-filing
1mo ago +2.9%1w ago +1.1%1d ago +1.8%
Returns since
7d30d90d180d1y

EW price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
EW since 2026-10-08Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001225208-26-008338
Common Stock
Transaction date
Oct 08, 2026
Filed Oct 08, 2026, 09:24 PM · 0d delay
Shares
619 sh
$72.68 per share
Estimated value
$44.9k
Computed from shares × price
Holdings after
40.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CVP, TAVR

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026.

Original filing · 0001225208-26-008338
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

EW